Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-017876
Filing Date
2022-05-12
Accepted
2022-05-12 21:03:29
Documents
2
Period of Report
2022-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14538
2 EX-99 DOCUMENT attachment1.htm EX-99 3459
  Complete submission text file 0000899243-22-017876.txt   19721
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BAUSCH HEALTH COMPANIES INC. 400 SOMERSET CORPORATE BLVD. BRIDGEWATER NJ 08807
Business Address
Spurr Robert (Reporting) CIK: 0001543795 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 22919859